Novo Nordisk Stock Today (November 20, 2025): Wegovy Price Cuts, Alzheimer’s ‘Lottery Ticket’ Trials and Denmark GDP Put NVO Back in the Spotlight
Novo Nordisk stock is back on traders’ screens today as a cluster of fresh headlines – from high‑stakes Alzheimer’s trials to aggressive Wegovy price cuts and new Danish GDP data – reshapes the narrative around the Ozempic maker. On Thursday, November 20, 2025, Novo Nordisk’s U.S.-listed ADR (ticker NVO) is trading around $49, roughly in line with Wednesday’s close, after a 3% rebound the previous day. StockInvest+1 In Copenhagen, Novo Nordisk’s Class B shares are last quoted around DKK 318–319, up roughly 2–2.5% on the session, according to data from Investing.com and TradingView. Investing.com+2Investing.com+2 At the same time, the company